tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graham Parry, 4 are a HOLD (40%), 1 are a SELL (10%), 5 are a BUY (50%).
Analyst Graham Parry, currently employed at BAML, carries an average stock price target met ratio of 72.22% that have a potential upside of 64.2% achieved within 2466 days.
Graham Parry’s has documented 17 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 12-Sep-2023.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 3/28/2023. The price target of $113.35 was fulfilled within 512 days with a profit of $33.33 (41.65%) receiving and performance score of 0.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 02-Feb-2023
$17.1
1 months 1 days ago
(06-Jan-2026)
0/12 (0%)
$-14.05 (-45.10%)
Buy Since 02-Dec-2024
$41
$-19.23 (-31.93%)
1 years 2 months 5 days ago
(02-Dec-2024)
1/1 (100%)
$8.1 (24.62%)
192
Hold Since 12-Nov-2024
$53
1 years 2 months 26 days ago
(12-Nov-2024)
4/4 (100%)
$17.12 (47.71%)
512
Buy Since 17-Mar-2023
1 years 6 months 6 days ago
(01-Aug-2024)
0/13 (0%)
$-16.16 (-42.73%)
Buy Since 30-Nov-2017
$45
$-15.23 (-25.29%)
$47
1 years 6 months 22 days ago
(16-Jul-2024)
3/3 (100%)
$8.47 (23.19%)
1558
What Year was the first public recommendation made by Graham Parry?
